Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2022 Feb;10(2):97-98.
doi: 10.1016/S2213-8587(21)00329-6. Epub 2021 Dec 15.

Dapagliflozin in patients with COVID-19: mind the kidneys

Thiago Reis  1 , Marlies Ostermann  2 , Alexander Zarbock  3 , John A Kellum  4 , Claudio Ronco  5
Affiliations
Comment

Dapagliflozin in patients with COVID-19: mind the kidneys

Thiago Reis et al. Lancet Diabetes Endocrinol. 2022 Feb.
No abstract available

PubMed Disclaimer

Conflict of interest statement

TR received consulting fees from Baxter and Contatti Medical (CytoSorbents) and payment or honoraria from AstraZeneca, Baxter, Contatti Medical (CytoSorbents), B Braun, Jafron, and Eurofarma. MO received lecture fees to their institution from bioMérieux, Fresenius Medical, and Baxter, and payment to their institution for participation on the advisory board for NxStage. AZ received grants from Baxter, bioMérieux, consulting fees from Guard Therapeutics, AM Pharma, and Piaon, payment or honoraria from Fresenius, Baxter, and bioMérieux, payment for participation in advisory boards for Guard Therapeutics, AM Pharma, and Fresenius, and payment for leadership on boards for ESAIC, A&A, and Anästhesist. JAK received grants or contracts, consulting fees, and payment or honoraria from Astute Medical/bioMérieux. CR received consulting fees and payment or honoria from ASAHI, Baxter, bioMérieux, B. Braun, CytoSorbents, ESTOR, Fresenius Medical Care, General Electric, Medtronic, and Toray.

Comment in

Comment on

References

    1. Kosiborod MN, Esterline R, Furtado RHM, et al. Dapagliflozin in patients with cardiometabolic risk factors hospitalised with COVID-19 (DARE-19): a randomised, double-blind, placebo-controlled, phase 3 trial. Lancet Diabetes Endocrinol. 2021;9:586–594. - PMC - PubMed
    1. Ronco C, Bellomo R, Kellum JA. Acute kidney injury. Lancet. 2019;394:1949–1964. - PubMed
    1. Chan L, Chaudhary K, Saha A, et al. AKI in hospitalized patients with COVID-19. J Am Soc Nephrol. 2021;32:151–160. - PMC - PubMed
    1. Heerspink HJL, Karasik A, Thuresson M, et al. Kidney outcomes associated with use of SGLT2 inhibitors in real-world clinical practice (CVD-REAL 3): a multinational observational cohort study. Lancet Diabetes Endocrinol. 2020;8:27–35. - PubMed
    1. Procaccini FL, Alcázar Arroyo R, Albalate Ramón M, et al. Acute kidney injury in 3182 patients admitted with COVID-19: a single-center, retrospective, case-control study. Clin Kidney J. 2021;14:1557–1569. - PMC - PubMed